FMT
KYNB

First Mercantile Trust’s Kyntra Bio KYNB Stock Holding History

First Mercantile Trust’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-123
Closed -$146K – 784
2017
Q4 		$146K Sell
123
-11
-8% -$13.8K 0.03% 628
2017
Q3 		$181K Buy
+134
New +$141K 0.03% 584
2016
Q1 		– Sell
-100
Closed -$76K – 886
2015
Q4 		$76K Buy
+100
New +$66.4K 0.01% 861

Other funds holding KYNB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

First Mercantile Trust's KYNB Position: Q1 2018 in Review

First Mercantile Trust sold out of Kyntra Bio (KYNB) in Q1 2018, closing a stake of 123 shares — an estimated $146K sold.

First Mercantile Trust first reported a position in KYNB in Q4 2015 and held it in 3 quarters. The position peaked at $181K in Q3 2017. 193 funds tracked by Wall St. Rank hold KYNB as of Q1 2018.

  • First Mercantile Trust reported no remaining Kyntra Bio position as of Q1 2018 after selling out during the quarter.
  • First Mercantile Trust sold 123 Kyntra Bio shares in Q1 2018, an estimated $146K.
  • First Mercantile Trust first reported a position in Kyntra Bio in Q4 2015 and held it in 3 quarters.
  • First Mercantile Trust's Kyntra Bio position peaked at $181K in Q3 2017.
  • 193 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2018.

Based on First Mercantile Trust's 13F filing for Q1 2018, filed 8 May 2018.